Clinical Trials Logo

Atrial Flutter Typical clinical trials

View clinical trials related to Atrial Flutter Typical.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03401099 Completed - Clinical trials for Atrial Flutter Typical

Cryoballoon Ablation as First Line Treatment of Atrial Flutter

CRAFT
Start date: August 17, 2018
Phase: N/A
Study type: Interventional

Current guidelines recommend radiofrequency catheter ablation of the cavotricuspid isthmus as treatment for symptomatic/drug-refractory atrial flutter, in spite of the fact that recurrences of flutter and incidence of post-ablation atrial fibrillation are common. In this study, the investigators assess the hypothesis that the use of cryoballoon Pulmonary Vein Isolation ('novel' treatment) to achieve the electrical disconnection between the pulmonary veins and the heart will lead to higher rates of freedom from abnormal heart rhythms (atrial flutter, atrial fibrillation, or atrial tachycardia) and more improved quality of life than treatment using heat energy (radiofrequency ablation) directed at the cavotricuspid isthmus ('conventional treatment').